U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.2324_2325del (p.Leu775fs) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Sep 21, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000130512.13

Allele description [Variation Report for NM_000465.4(BARD1):c.2324_2325del (p.Leu775fs)]

NM_000465.4(BARD1):c.2324_2325del (p.Leu775fs)

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.2324_2325del (p.Leu775fs)
HGVS:
  • NC_000002.12:g.214728685_214728686del
  • NG_012047.3:g.86026_86027del
  • NM_000465.4:c.2324_2325delMANE SELECT
  • NM_001282543.2:c.2267_2268del
  • NM_001282545.2:c.971_972del
  • NM_001282548.2:c.914_915del
  • NM_001282549.2:c.785_786del
  • NP_000456.2:p.Leu775fs
  • NP_001269472.1:p.Leu756fs
  • NP_001269474.1:p.Leu324fs
  • NP_001269477.1:p.Leu305fs
  • NP_001269478.1:p.Leu262fs
  • LRG_297t1:c.2324_2325del
  • LRG_297:g.86026_86027del
  • LRG_297p1:p.Leu775fs
  • NC_000002.11:g.215593409_215593410del
  • NG_012047.2:g.86019_86020del
  • NM_000465.2:c.2324_2325del
  • NM_000465.2:c.2324_2325delTT
  • NM_000465.3:c.2324_2325del
  • NM_000465.3:c.2324_2325delTT
  • NR_104212.2:n.2289_2290del
  • NR_104215.2:n.2232_2233del
  • NR_104216.2:n.1488_1489del
  • p.L775Rfs*19
Protein change:
L262fs
Links:
dbSNP: rs587782046
NCBI 1000 Genomes Browser:
rs587782046
Molecular consequence:
  • NM_000465.4:c.2324_2325del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001282543.2:c.2267_2268del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001282545.2:c.971_972del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001282548.2:c.914_915del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001282549.2:c.785_786del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_104212.2:n.2289_2290del - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.2232_2233del - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104216.2:n.1488_1489del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000185381Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Sep 21, 2023)
germlineclinical testing

Citation Link,

SCV000682772Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jun 23, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Ambry Genetics, SCV000185381.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.2324_2325delTT variant, located in coding exon 11 of the BARD1 gene, results from a deletion of two nucleotides at nucleotide positions 2324 to 2325. This alteration changes the last three residues of the BARD1 protein and results in the elongation of the protein by 15 amino acids before introducing an alternate stop codon (p.L775Rfs*19). This alteration occurs at the 3' terminus of theBARD1 gene, is not expected to trigger nonsense-mediated mRNAdecay and results in the elongation of the protein by 15 amino acids. This frameshift impacts the last 3amino acids of the native protein. The exact functional effect of the altered amino acids is unknown. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV000682772.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024